Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dobutamine Effects on Cardiac Conduction
NCT04249258Phase 1Completed
- Sponsor
- Northwell Health
- Start
- Jan 2020
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of dobutamine in Cardiac arrhythmias, sponsored by Northwell Health. Primary endpoints: Change in sinus cycle length and Change in anterograde atrioventricular node Wenckebach cycle length. Started Jan 2020; status: completed.
02
Drugs
dobutamine
03
Conditions
Cardiac arrhythmias
Beyond the preview
Go deeper on NCT04249258.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04249258.